{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T11:36:25Z","timestamp":1778412985199,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semarthritisrheumatism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.semarthrit.2014.12.005","type":"journal-article","created":{"date-parts":[[2014,12,27]],"date-time":"2014-12-27T00:45:42Z","timestamp":1419641142000},"page":"717-723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"title":["Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients"],"prefix":"10.1016","volume":"44","author":[{"given":"Javier","family":"Loricera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 L.","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santos","family":"Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Mera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"P\u00e9rez-Pamp\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enriqueta","family":"Peir\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Humbr\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Calvo-Al\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Aurrecoechea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Narv\u00e1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amalia","family":"S\u00e1nchez-Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paloma","family":"Vela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvira","family":"D\u00edez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Mata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pau","family":"Lluch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concepci\u00f3n","family":"Moll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00cd\u00f1igo","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanesa","family":"Calvo-R\u00edo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Ortiz-Sanju\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Gonz\u00e1lez-Vela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trinitario","family":"Pina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel \u00c1.","family":"Gonz\u00e1lez-Gay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2014.12.005_bib1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1056\/NEJMra011913","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"347","author":"Salvarani","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib2","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/art.24459","article-title":"Epidemiology of giant cell arteritis and polymyalgia rheumatica","volume":"61","author":"Gonzalez-Gay","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00005792-200009000-00001","article-title":"Visual manifestations of giant cell arteritis: trends and clinical spectrum in 161 patients","volume":"79","author":"Gonz\u00e1lez-Gay","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib4","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1161\/CIRCULATIONAHA.107.760686","article-title":"Aortitis","volume":"117","author":"Gornik","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.md.0000145366.40805.f8","article-title":"Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study","volume":"83","author":"Gonzalez-Gay","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib6","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-122-7-199504010-00004","article-title":"Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis: a population-based study","volume":"122","author":"Evans","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib7","article-title":"Non-infectious aortitis: a report of 32 cases from a single tertiary centre in a 4-year period and literature review","author":"Loricera","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib8","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.4049\/jimmunol.175.6.3463","article-title":"Directing transition from innate to acquired immunity: defining a role for IL-6","volume":"175","author":"Jones","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/gerona\/57.4.M241","article-title":"Arterial wall production of cytokines in giant cell arteritis: results of a pilot study using human temporal artery cultures","volume":"57","author":"Blain","year":"2002","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib10","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/j.2326-5205.1989.tb00020.x","article-title":"Immunohistochemical analysis of lymphoid and macrophage cell subsets and their immunologic activation markers in temporal arteritis: influence of corticosteroid treatment","volume":"32","author":"Cid","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/art.11388","article-title":"Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes","volume":"49","author":"Proven","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib12","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MD.0b013e31821c4fad","article-title":"Relapses and recurrences in giant cell arteritis: a population-based study of patients with biopsy-proven disease from northwestern Spain","volume":"90","author":"Martinez-Lado","year":"2011","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib13","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/art.10262","article-title":"A multicenter, randomized, double blind, placebo-controlled trial of adjuvant MTX treatment for giant cell arteritis","volume":"46","author":"Hoffman","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7326\/0003-4819-134-2-200101160-00010","article-title":"Combined treatment of giant cell arteritis with MTX and prednisone: a randomized, double-blind, placebo-controlled trial","volume":"134","author":"Jover","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib15","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1002\/art.22754","article-title":"Adjunctive MTX for treatment of giant cell arteritis: an individual patient data meta-analysis","volume":"56","author":"Mahr","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib16","first-page":"495","article-title":"A prospective, double-blind, randomized, placebo controlled trial of MTX in the treatment of giant cell arteritis (GCA)","volume":"19","author":"Spiera","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/ard.45.2.136","article-title":"Azathioprine in giant cell arteritis\/polymyalgia rheumatica: a double-blind study","volume":"45","author":"De Silva","year":"1986","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib18","first-page":"S43","article-title":"Cyclophosphamide for large vessel vasculitis: assessment of response by PET\/CT","volume":"29","author":"Henes","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-146-9-200705010-00004","article-title":"Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial","volume":"146","author":"Hoffman","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib20","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/annrheumdis-2013-203586","article-title":"Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomized controlled trial","volume":"73","author":"Seror","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib21","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJMra022694","article-title":"Medium- and large-vessel vasculitis","volume":"349","author":"Weyand","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib22","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/rheumatology\/29.6.456","article-title":"Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis","volume":"29","author":"Dasgupta","year":"1990","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0198-8859(94)90096-5","article-title":"Production of interleukin 6 by granulomas of giant cell arteritis","volume":"39","author":"Emilie","year":"1994","journal-title":"Hum Immunol"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/BOR.0b013e32835b133a","article-title":"New treatment strategies in large-vessel vasculitis","volume":"25","author":"Unizony","year":"2013","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl. 3","key":"10.1016\/j.semarthrit.2014.12.005_bib25","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1186\/ar565","article-title":"The paradigm of IL-6: from basic science to medicine","volume":"4","author":"Naka","year":"2002","journal-title":"Arthritis Res"},{"issue":"Suppl. 82","key":"10.1016\/j.semarthrit.2014.12.005_bib26","first-page":"79","article-title":"Tocilizumab in refractory aortitis: study on 16 patients and literature review","volume":"32","author":"Loricera","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl. 75","key":"10.1016\/j.semarthrit.2014.12.005_bib27","first-page":"S59","article-title":"Tocilizumab in glucocorticoid-na\u00efve large-vessel vasculitis. Case report","volume":"31","author":"Pazzola","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib28","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1136\/ard.2010.149351","article-title":"Anti-interleukin 6 receptor therapy as rescue treatment for giant cell arteritis","volume":"70","author":"Beyer","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.04.2011.4135","article-title":"Successful use of tocilizumab in polymyalgic onset biopsy positive GCA with large vessel involvement","author":"Christidis","year":"2011","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/rheumatology\/ker296","article-title":"Tocilizumab: a novel therapy for patients with large-vessel vasculitis","volume":"51","author":"Salvarani","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib31","first-page":"w13156","article-title":"Rapid induction of remission in large vessel vasculitis by IL-6 blockade: a case series","volume":"141","author":"Seitz","year":"2011","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib32","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/acr.21750","article-title":"Tocilizumab for the treatment of large- vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatic","volume":"64","author":"Unizony","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib33","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.3899\/jrheum.110496","article-title":"Interleukin 6 blockade as steroid-sparing treatment for 2 patients with giant cell arteritis","volume":"38","author":"Sciascia","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib34","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib35","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-97-5-672","article-title":"Polymyalgia rheumatica: a 10-year epidemiologic and clinical study","volume":"97","author":"Chuang","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib36","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s11926-010-0135-9","article-title":"Giant cell arteritis: epidemiology, diagnosis, and management","volume":"12","author":"Gonzalez-Gay","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib37","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10067-013-2384-2","article-title":"Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis","volume":"33","author":"Yates","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib38","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/ard.2007.082115","article-title":"A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects","volume":"67","author":"Mart\u00ednez-Taboada","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/BOR.0b013e32834dc392","article-title":"Biologic treatment of large-vessel vasculitides","volume":"24","author":"Schafer","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib40","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.semarthrit.2013.07.010","article-title":"Biological therapy for systemic vasculitis: A systematic review","volume":"43","author":"Silva-Fern\u00e1ndez","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib41","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/art.38398","article-title":"Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still\u2019s disease: multicenter retrospective open-label study of thirty-four patients","volume":"66","author":"Ortiz-Sanju\u00e1n","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib42","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1136\/annrheumdis-2013-204572","article-title":"Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsy-proven giant cell arteritis: a prospective, case\u2013control study","volume":"73","author":"Prieto-Gonz\u00e1lez","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01.md.0000180042.42156.d1","article-title":"Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients","volume":"84","author":"Gonzalez-Gay","year":"2005","journal-title":"Medicine"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib44","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.semarthrit.2003.09.007","article-title":"Giant cell arteritis and polymyalgia rheumatic: two different but often overlapping conditions","volume":"33","author":"Gonzalez-Gay","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib45","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1517\/14656561003724739","article-title":"Medical management of polymyalgia rheumatica","volume":"11","author":"Gonzalez-Gay","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib46","article-title":"Glucocorticoid-resistant polymyalgia rheumatic: pretreatment characteristics and tocilizumab therapy","author":"Mori","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib47","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/RHU.0b013e3182a6aa0e","article-title":"Effective control of polymyalgia rheumatica with tocilizumab","volume":"19","author":"Al Rashidi","year":"2013","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-009523","article-title":"Refractory PMR with aortitis: life-saving treatment with anti-IL6 monoclonal antibody (tocilizumab) and surgical reconstruction of the ascending aorta","volume":"2013","author":"Ashraf Fa","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib49","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.semarthrit.2013.01.003","article-title":"Tocilizumab for polymyalgia rheumatica: report of two cases and review of the literature","volume":"43","author":"Macchioni","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.12.005_bib50","doi-asserted-by":"crossref","first-page":"912562","DOI":"10.1155\/2013\/912562","article-title":"Design of the tocilizumab in giant cell arteritis trial","volume":"2013","author":"Unizony","year":"2013","journal-title":"Int J Rheumatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901721400328X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004901721400328X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T04:41:17Z","timestamp":1690778477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004901721400328X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S004901721400328X"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2014.12.005","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2014.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}